Evrysdi (risdiplam) for the Treatment of Spinal Muscular Atrophy (SMA)
Evrysdi™ is intended to treat SMA by improving motor neuron (SMN) protein survival efficiency. Credit: Alila Medical Media/Shutterstock.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
